Press Release

Kaiku Health expands rapidly to European cancer centers

Cancer centers in Naples, Nuremberg and Furth have applied Netmedi’s Kaiku Health –platform for the electronic follow-up of the cancer treatments and patients’ quality of life. In Sweden, Kaiku® Health is used in a national research project coordinated from Gothenburg.

One of the leading immunotherapy centers in the world selected Kaiku Health for systematic follow-up of patients treated with immune checkpoint inhibitors.

“The adverse event profile of immunotherapy differs from conventional oncological treatments. Thus, it sets new requirements for patient follow-up. Kaiku Health is a system which allows us to detect and treat the symptoms early on,” explains Professor Paulo A. Ascierto, Director at National Tumor Institute Fondazione G. Pascale, Naples, Italy.

In Germany, Kaiku® Health is implemented for electronic patient follow-up at two new cancer clinics located in Nuremberg and Fürth. In Sweden, Kaiku Health –platform is used for digital collection of research data in a national phase 4 clinical trial coordinated from Gothenburg.

“Our digital platform has already supported the healthcare of over 20 000 people globally. These new European clients are further accelerating our international growth during 2017 and beyond. Kaiku Health will be supporting a rapidly growing number of patients and their quality of lives,” says Lauri Sippola, CEO and Co-founder of Netmedi Ltd.


For more information, please contact

Lauri Sippola
+358 40 744 7481

Related items

More recent news


Get in touch with us

Interested in learning more about Kaiku Health? Send us a note